Prime Medicine Announces Leadership Transition: Dr. Allan Reine Appointed CEO as Keith Gottesdiener Steps Down

Reuters
2025.05.19 12:31
portai
I'm PortAI, I can summarize articles.

Prime Medicine Inc. has announced a leadership transition, with Dr. Allan Reine appointed as the new CEO, succeeding Keith Gottesdiener, who has stepped down immediately. Dr. Reine, previously the CFO, will also join the Board of Directors. Jeff Marrazzo has been named Executive Chair. Gottesdiener will continue as a consultant for one year.

Prime Medicine Inc. has announced a change in its management team. Keith Gottesdiener, M.D., has stepped down as CEO and member of the Board of Directors, effective immediately. Allan Reine, M.D., previously the company's CFO, has been appointed as the new CEO and will join the Board of Directors. Jeff Marrazzo, currently a Board member, has been named Executive Chair. Dr. Gottesdiener will remain with the company as a consultant for one year.

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.